Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to provide a general business update on its progress across its three core lines of business:
Nutraceuticals – MVMD has made significant strides with its Quicksome™ technology, designed to enhance the administration and effectiveness of nutraceutical health and wellness products.
Agriculture – The Company’s Agrarius agricultural plant signaling technology aims to organically boost crop yields and overall plant health, with the potential to reduce fertilizer and pesticide use.
Husbandry Animals/Aquatic Species – MVMD is utilizing its Quicksol™ technology to apply solubilized drugs, positively impacting the health of husbandry animals and aquatic species.
President & CEO Dennis Hancock expressed his pride in the team, stating: “This past six months has been transformative for MVMD and our extensive partner network as our technologies gain positive reception in the marketplace. Our team has worked tirelessly during this pivotal phase, delivering innovative products with unique value propositions while scaling our operations and expanding our strategic partnerships.”
BUSINESS UPDATES
NUTRACEUTICALS
Quicksome™ Powered Products and Business Development Progress
MVMD’s U.S. manufacturing partner, Lead Manufacturer, has completed equipment set-up and testing to produce nutraceutical applications for MVMD’s Quicksome™ technology, including sublingual rapid dissolve tablets and powders. The GMP manufacturing facility is now fully operational and supporting Quicksome™ related business development and manufacturing.
The Lead Manufacturer has collaborated with MVMD on initial product and production elements for Circadian Wellness, mushroom-based nutraceutical products, and MVMD’s proprietary product line “Mountains Of…” along with potential new licensees.
MVMD has finalized product formulations for Circadian’s Eons branded lineup, including sleep, energy, immunity, and a new amanita mushroom product. Circadian began selling its Eons Deeper Sleep sublingual sleep product in February 2024, using MVMD’s technology, with additional products ready for manufacturing and anticipated rollout through 2024.
Eons Deeper Sleep’s rapid dissolve format utilizes Quicksome™ technology to enable effective, rapid onset with reduced ingredient quantities. Internal testing, led by Director of Research and Development Richa Mandalay, used wearable devices to track sleep biometrics, validating the product’s efficacy.
MVMD’s business development with Lead Manufacturer includes proprietary formulation projects with multiple business prospects, including an opioid use disorder (OUD) solution. Samples have been created for clinical trials planned for Q3 2024.
To support future business development, MVMD has completed Quicksome™ formulations for a broad product line, including sleep, energy, appetite suppressant, pain relief, focus, stress, and anxiety relief.
AGRICULTURE
Agrarius Business Development and Product Registration/Salability Advancements including Brazil, Colombia, and Canada
MVMD executed an Amended and Restated Supply and License Agreement with Agrarius Corp. (AC), acquiring an exclusive license for AC’s plant signaling technology in North America, Mexico, South America, Central America, and the Caribbean. The OMRI-certified Agrarius product aims to naturally increase yields, reduce fertilizer usage, and enhance resilience to pests and climate change.
Agrarius has demonstrated significant yield increases and reduced fertilizer usage in numerous crop trials. MVMD’s agronomists, in collaboration with third-party agricultural testing partners and academic institutions, have conducted extensive studies, showing positive impacts on plant health and yields.
MVMD is actively conducting business development in Mexico, Central America, South America, Canada, and the USA. Agrarius is now saleable in the EU, 44 US states, Canada, and Brazil. Colombia received import approval on July 19, 2024, with final approval anticipated by early August 2024. Additional approvals are expected in Panama, Costa Rica, Peru, Uruguay, and Mexico through 2024.
“We believe the recent registration in Brazil is significant for our commercialization plans and long-term shareholder value,” said Hancock. “Brazil is one of the largest agricultural markets, and we have a strong business development pipeline, including collaborations with top agricultural organizations.”
MVMD has filed for Agrarius trademark protection in Brazil, Mexico, Chile, Colombia, Uruguay, Panama, Costa Rica, Peru, Ecuador, Argentina, Paraguay, and Bolivia.
MVMD launched a Performance Guarantee Program targeting farm operations in Canada and the USA, allowing clients to pay for Agrarius only after achieving a minimum agreed performance enhancement. The program aims to demonstrate Agrarius’s effectiveness while minimizing financial risk for clients.
To support business development and the Performance Guarantee Program, MVMD has updated the Agrarius brand, including international website content and a brand positioning video in English, Spanish, and Portuguese.
With recent registration confirmations and anticipated approvals, MVMD expects initial Agrarius-related revenues in Q4 2024.
